To the G20:: incentivising antibacterial research and development

Christine Årdal; Enrico Baraldi; Francesco Ciabuschi; Kevin Outterson; John H Rex; Laura J V Piddock; David Findlay; DRIVE-AB Steering Committee

doi:10.1016/S1473-3099(17)30404-8

To the G20: incentivising antibacterial research and development

Christine Årdal
, Enrico Baraldi
, Francesco Ciabuschi
, Kevin Outterson
, John H Rex
, Laura J V Piddock
, David Findlay
, DRIVE-AB Steering Committee

Research output: Contribution to journal › Comment/debate › peer-review

16 Citations (Scopus)

322 Downloads (Pure)

Original language	English
Pages (from-to)	799-801
Journal	The Lancet Infectious Diseases
Volume	17
Issue number	8
Early online date	7 Jul 2017
DOIs	https://doi.org/10.1016/S1473-3099(17)30404-8
Publication status	Published - Aug 2017

Access to Document

10.1016/S1473-3099(17)30404-8Licence: None: All rights reserved

Årdal_et_al_To_the_G20_incentivising_antibacterial_research_The_Lancet_Infectious_Diseases_2017Accepted author manuscript, 441 KBLicence: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

http://www.sciencedirect.com/science/article/pii/S1473309917304048Licence: None: All rights reserved

Cite this

@article{6cae2b0f44004f52a8e3ec45955c0903,

title = "To the G20:: incentivising antibacterial research and development",

author = "Christine {\AA}rdal and Enrico Baraldi and Francesco Ciabuschi and Kevin Outterson and Rex, \{John H\} and Piddock, \{Laura J V\} and David Findlay and \{DRIVE-AB Steering Committee\}",

year = "2017",

month = aug,

doi = "10.1016/S1473-3099(17)30404-8",

language = "English",

volume = "17",

pages = "799--801",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier",

number = "8",

}

TY - JOUR

T1 - To the G20:

T2 - incentivising antibacterial research and development

AU - Årdal, Christine

AU - Baraldi, Enrico

AU - Ciabuschi, Francesco

AU - Outterson, Kevin

AU - Rex, John H

AU - Piddock, Laura J V

AU - Findlay, David

AU - DRIVE-AB Steering Committee

PY - 2017/8

Y1 - 2017/8

U2 - 10.1016/S1473-3099(17)30404-8

DO - 10.1016/S1473-3099(17)30404-8

M3 - Comment/debate

C2 - 28689703

SN - 1473-3099

VL - 17

SP - 799

EP - 801

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 8

ER -